Ofatumumab sBLA Is Accepted for Treatment of Relapsing Multiple Sclerosis

The novel B-cell therapy has been assigned a PDUFA date of June 2020.

Source link

Related posts

5 Ways to Boost Stress Resilience


REM sleep as predictor of functional outcome after stroke: A translational study.


Neurology outreach clinic for Huntington disease in Peru: Lessons for neurodegenerative diseases


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World